We're changing the way Sapphire looks
Same platform, new visual identity. Learn more: Sapphire is becoming NHMRC Grant Management System.
We're changing the way Sapphire looks
Same platform, new visual identity. Learn more: Sapphire is becoming NHMRC Grant Management System.
The Vitamin K administration to newborn infants to prevent vitamin K deficiency bleeding in infancy recommendations for Vitamin K to be given to newborn children.
Clinicians, government health departments, professional colleges and the Council of NHMRC in 2010 contributed to the development of this statement.
The NHMRC has re-issued the Joint statement and recommendations on vitamin K administration to newborn infants to prevent vitamin K deficiency bleeding in infancy. Vitamin K is administered to newborns to prevent vitamin K deficiency bleeding (VKDB).
The recommendations in the Joint statement and recommendations on vitamin K administration to newborn infants to prevent vitamin K deficiency bleeding in infancy remain unchanged after being widely consulted, including receiving advice from clinicians, government health departments, professional colleges and the Council of the NHMRC.
The NHMRC CEO approved the re-issuing of the joint statement on 2 November 2010.